Clinical Trial Update: Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers [Phase 3]

View source ↗

Summary

Phase 3 trial update for avatrombopag in adults with chemotherapy-induced thrombocytopenia shows results upon trial completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia

Drugs mentioned

• Avatrombopag (avatrombopag)

Snippet

Sponsor: Sobi, Inc. | Conditions: Chemotherapy-induced Thrombocytopenia | Phase 3 | Status: COMPLETED | Results posted: 2021-11-24